Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.99 USD | +1.69% |
|
+2.60% | +7.91% |
| 06-30 | BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating | MT |
| 06-29 | Edwards Lifesciences Secures US FDA Approval for Ecliptis System | MT |
| Market Cap | 52.97B 46.51B 42.81B 39.89B 75.23B 5,036B 76.76B 515B 199B 2,472B 199B 195B 8,603B | P/E 2026 * |
32.8x | P/E 2027 * | 28.1x |
|---|---|---|---|---|---|
| Enterprise Value | 49.49B 43.45B 39.99B 37.27B 70.28B 4,705B 71.71B 481B 186B 2,309B 186B 182B 8,037B | EV / Sales 2026 * |
7.33x | EV / Sales 2027 * | 6.46x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.69% | ||
| 1 week | +2.60% | ||
| Current month | +1.69% | ||
| 1 month | +4.34% | ||
| 3 months | +13.20% | ||
| 6 months | +7.91% | ||
| Current year | +7.91% |
| 1 week | 89.33 |  | 92.88 |
| 1 month | 83.17 | | 92.88 |
| Current year | 74.66 | | 92.88 |
| 1 year | 72.3 | | 92.88 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 05-28 | Sell | Controller/Auditor | -568 | 0.0001% | ||
| 05-26 | Sell | Executive/Senior Manager | -23,145 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | +2.60% | +19.19% | -2.48% | 52.09B | |
| +2.39% | +4.29% | +21.80% | -1.61% | 186B | |
| +1.18% | +0.14% | -25.21% | +17.68% | 141B | |
| +1.70% | +2.57% | -3.67% | -19.28% | 135B | |
| +0.89% | -3.15% | -58.90% | -20.39% | 63.44B | |
| +0.82% | +0.73% | -26.51% | -33.51% | 43.6B | |
| +0.42% | +1.34% | +10.74% | +10.93% | 37.52B | |
| +0.82% | +2.42% | +5.91% | +41.87% | 36.82B | |
| +1.33% | -0.03% | -14.60% | -20.16% | 29.12B | |
| +3.19% | +2.34% | -21.53% | -7.96% | 28.14B | |
| Average | +1.33% | +0.25% | -9.28% | -3.49% | 75.27B | |
| Weighted average by Cap. | +1.38% | +0.50% | -5.70% | -2.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.75B 5.92B 5.45B 5.08B 9.58B 642B 9.78B 65.59B 25.41B 315B 25.34B 24.79B 1,096B | 7.41B 6.51B 5.99B 5.58B 10.52B 705B 10.74B 72.03B 27.91B 346B 27.82B 27.22B 1,204B |
| Net income | 1.62B 1.43B 1.31B 1.22B 2.31B 154B 2.35B 15.79B 6.12B 75.8B 6.1B 5.97B 264B | 1.89B 1.66B 1.53B 1.42B 2.69B 180B 2.74B 18.38B 7.12B 88.25B 7.1B 6.95B 307B |
| Net Debt | -3.48B -3.06B -2.81B -2.62B -4.95B -331B -5.05B -33.85B -13.11B -163B -13.08B -12.79B -566B | -5.07B -4.45B -4.1B -3.82B -7.2B -482B -7.35B -49.31B -19.1B -237B -19.05B -18.63B -824B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | US$91.99 | +1.69% | 4,284,003 |
| 26-06-30 | US$90.46 | -0.79% | 3,627,318 |
| 26-06-29 | US$91.18 | +0.44% | 3,606,384 |
| 26-06-26 | US$90.78 | +1.18% | 14,420,825 |
| 26-06-25 | US$89.72 | +0.07% | 4,318,766 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
